Why would scores of investors from across the world want to pile into loss-making companies in a sector that is at the mercy of China's notoriously unpredictable regulators There are 1.3 billion good reasons.
The world's most populous nation is pushing hard to revamp a health sector that has long struggled with an imbalance between growing patient numbers and limited resources. China's growing middle class is demanding better healthcare and the country's leadership, ever mindful of meeting public aspirations for better living standards, is reacting with policy changes that a range of startups are eager to take advantage of.
That's led to strong investments in companies in...
¬ Haymarket Media Limited. All rights reserved.
